CDK1/2/4-IN-1

Name: CDK1/2/4-IN-1
Brand: TargetMol
SKU: T60583
Price: 677 USD
Availability: InStock
Rating: 4.5 (1 reviews)

还可以

产品编号 T60583Cas号 2414633-49-9

CDK1/2/4-IN-1 (compound 3a) 是 CDK 的有效抑制剂，其对于 CDK1、CDK2 和 CDK4 的 IC50值分别为 1.47、0.78 和 0.87 μM。CDK1/2/4-IN-1 可用于癌症研究。CDK1/2/4-IN-1 可将细胞周期阻滞在 G2/M 期并诱导细胞凋亡。CDK1/2/4-IN-1 提高 Bax、caspase-3和 P53 的水平并降低 Bcl-2 水平。

CDK1/2/4-IN-1

还可以

产品编号 T60583Cas号 2414633-49-9

规格	价格	库存
25 mg	¥ 10,600	6-8周
50 mg	¥ 13,800	6-8周
100 mg	¥ 17,500	6-8周

大包装 & 定制

加入购物车

实验操作小课堂

联系我们获取更多批次信息

资源下载

产品操作手册

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性

产品描述

CDK1/2/4-IN-1 (compound 3a) is a potent inhibitor of CDK with IC 50 values of 1.47, 0.78 and 0.87 μM for CDK1, CDK2 and CDK4, respectively. CDK1/2/4-IN-1 can be used in cancer research. CDK1/2/4-IN-1 arrests cell cycle at G2/M phase and induces apoptosis. CDK1/2/4-IN-1 elevates the level of Bax, caspase-3, and P53 and decreases the level of Bcl-2 [1].

体外活性

CDK1/2/4-IN-1 (compound 3a) (0.01-100 μM; 24 hours) has antitumor activity in cancer cell lines [1]. CDK1/2/4-IN-1 (compound 3a) (1.39 μM; 24 hours) induces apoptosis and arrests cell cycle at G2/M phase in A549 cells [1]. CDK1/2/4-IN-1 (compound 3a) (1.39 μM; A549 cells) induces up-regulation of the expression of Bax, caspases-3 and p53, and increases the ratio of Bcl-2 [1]. Cell Cytotoxicity Assay [1] Cell Line: Liver cancer cell line (HepG-2), lung cancer cell line (A549) and breast cancer cell line (MCF-7) Concentration: 0.01, 0.1, 1.0, 10, 100 μM Incubation Time: 24 hours Result: Displayed cytotoxic activity with IC 50 values of 1.56, 1.39 and 1.97 μM for HepG-2, A549 and MCF-7, respectively. Cell Cycle Analysis [1] Cell Line: A549 cells Concentration: 1.39 μM Incubation Time: 24 hours Result: Increased G2/M phase by 2.6 folds compared with the control cells. Apoptosis Analysis [1] Cell Line: A549 cells Concentration: 1.39 μM Incubation Time: 24 hours Result: Increased the overall percentage of the apoptotic cells.